Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
about
Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.Management of vasovagal syncope.Neurohormonal profile before and after beta-blockade in patients with neurocardiogenic syncope.Driving safety among patients with neurocardiogenic (vasovagal) syncope.Neurally mediated syncope.Management of vasovagal syncope: 2004.Dynamic changes in the QT-R-R relationship during head-up tilt test in patients with vasovagal syncope.Prognostic value of head-up tilt test with intravenous beta-blocker administration in assessing the efficacy of therapy in patients with vasovagal syncope.Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.Neurocardiogenic syncope: latest pharmacological therapies.Comparison of recurrence rate based on the frequency of preceding symptoms in patients with neurocardiogenic syncope or presyncope[Treatment of syncope].Vasovagal syncope: an update on the latest pharmacological therapies.Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy.Asystolic cardiac arrest during head-up tilt test: incidence and therapeutic implications.Sudden Wenckebach periods and their relationship to neurocardiogenic syncope.Heart rate variability during head-up tilt testing in patients with suspected neurally mediated syncope.Improved quality of life after treatment of prolonged asystole during breath holding spells with a cardiac pacemaker.
P2860
Q33144564-84A47B62-A01A-4679-8E11-7E72C2CE0EBDQ33144810-A1502846-D3A3-4C98-A6DD-9B3BB9B93E93Q33144929-6C115E89-3A09-400A-A5F4-629263932B0FQ33145173-9BD9CA0C-275C-4755-9A54-BA2E209DA3C1Q33145914-3FDF78F4-9E1C-44D3-B749-563FDF6BF291Q33151984-DB50FF11-FC9B-44C9-A085-E087A093B714Q33152241-BC2E2EA2-32E0-4920-A4F1-A5088706F492Q33152244-3027CD23-C341-4D35-A61D-D3107B3301CFQ33153736-49366F87-2462-4D05-A848-44CB9018F359Q33153898-7CDDA94F-2A53-47EB-8B25-899B60799CCEQ33160498-73A07E45-F693-46AB-B775-41BCEDD6470EQ33164162-3AF2486A-201A-41BC-B2B0-8400FC87710FQ33165101-BCF6B34F-8C1E-42F2-97F9-F782E8BC8C12Q33174985-263C9493-8530-4C8E-A87F-6F6A2F2A8FE5Q33175138-32C37714-0A76-4103-82C9-076B90D3D56CQ33175439-5AA0D9FC-89E5-4760-8EE8-5E012806A6E1Q33175753-C17B30D4-4DEF-4144-8691-38C295ADC7D8Q33175875-E9FFE457-8EE8-49AB-A8F1-CFCE1FCE4BEAQ40824964-FF810129-8A2D-473F-8EAA-8176B3E5514D
P2860
Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
@ast
Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
@en
type
label
Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
@ast
Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
@en
prefLabel
Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
@ast
Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
@en
P2093
P1476
Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
@en
P2093
Castellanos A
Myerburg RJ
Perlman BA
Silberstein TA
P304
P356
10.1016/0735-1097(95)00320-7
P407
P577
1995-11-01T00:00:00Z